- Medical School - Wake Forest University School of Medicine (2008-2012)
- Fellowship - UT Southwestern Medical Center (2016-2019), Gastroenterology
- Residency - UT Southwestern Medical Center (2013-2015), Internal Medicine
- Internship - UT Southwestern Medical Center (2012-2013), Internal Medicine
Ariel Aday, M.D.
Associate Program Director for the Gastroenterology Fellowship Program
- Internal Medicine - Digestive & Liver Diseases
Ariel Aday, M.D., grew up in Bristol, Virginia/Tennessee, and earned her medical degree at Wake Forest University School of Medicine in Winston-Salem, North Carolina. Following medical school, she moved to Dallas to complete her residency in internal medicine at UT Southwestern. After serving an additional year as Chief Resident in Internal Medicine, she went on to complete a gastroenterology fellowship at UT Southwestern.
Dr. Aday joined the faculty at UT Southwestern in 2019, and brings enthusiasm for medical education and clinical research.
She has a strong foundation in both general gastroenterology and hepatology as well as general internal medicine. Her clinical and research interests are in cirrhosis, alcoholic liver disease, women’s health, and nutrition.
Dr. Aday’s interests outside of
medicine include spending time with her family, traveling, and fitness.
- Dallas County Medical Society (2015), Member
- Texas Medical Association (2015), Member
- American Medical Association (2008), Member
- American Medical Women's Association (2008), Member
CON ("The window is closed"): In patients with cirrhosis with ascites, the clinical risks of nonselective beta-blocker outweigh the benefits and should NOT be prescribed.
Aday AW, Rich NE, Mufti AR, Tujios SR, Clinical liver disease 2018 May 11 5 123-127
DSA's Meaningful Impact on Liver Transplantation.
Aday AW, O'Leary JG Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2018 Jul
Food for Thought: Importance of Nutrition in Alcoholic Hepatitis
Ariel W Aday, Mack C Mitchell, Practical Gastroenterology, 2018
Alcoholic hepatitis: current trends in management.
Aday AW, Mitchell MC, Casey LC Current opinion in gastroenterology 2017 Mar
The Beneficial Effect of Beta-Blockers in Patients With Cirrhosis, Portal Hypertension and Ascites.
Aday AW, Mayo MJ, Elliott A, Rockey DC The American journal of the medical sciences 2016 Feb 351 2 169-76
An unusual rash in a middle-aged man.
Pandey A, Aday A Journal of general internal medicine 2014 Dec 29 12 1711-2
An essential role for the association of CD47 to SHPS-1 in skeletal remodeling.
Maile LA, DeMambro VE, Wai C, Lotinun S, Aday AW, Capps BE, Beamer WG, Rosen CJ, Clemmons DR Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2011 Sep 26 9 2068-81
Integrin-associated protein association with SRC homology 2 domain containing tyrosine phosphatase substrate 1 regulates igf-I signaling in vivo.
Maile LA, Capps BE, Miller EC, Aday AW, Clemmons DR Diabetes 2008 Oct 57 10 2637-43
Modulation of integrin antagonist signaling by ligand binding of the heparin-binding domain of vitronectin to the alphaVbeta3 integrin.
Maile LA, Aday AW, Busby WH, Sanghani R, Veluvolu U, Clemmons DR Journal of cellular biochemistry 2008 Oct 105 2 437-46
Acute Liver Failure (ALF) in Pregnancy: How Much Is Pregnancy-Related?
Casey LC, Fontana RJ, Aday A, Nelson DB, Rule JA, Gottfried M, Tran M, Lee WM, Hepatology (Baltimore, Md.) 2020 Jan
- CON ("The window is closed"): In patients with cirrhosis with ascites, the clinical risks of nonselective beta-blocker outweigh the benefits and should NOT be prescribed.